----
Current ValuationThe current P/E ratio is -29.85, within the reasonable range, cheaper than 89.72% of the time in the past 5 years, and the industry ranks 26/29, the industry Median -1.44.
-29.85xP/E
HK$2.64Stock price
HK$-0.09Earnings per share
-29.85xP/E
Stock priceHK$2.64Earnings per shareHK$-0.09
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 14.02x
- Typical range
- -29.85x–16.87x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
0143286429572
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x40x80x120x160x200x
| Name/Symbol | |||
|---|---|---|---|
01448HKFU SHOU YUAN | -29.85x | -- | HK$6.12B |
03893HKCROSSTEC | -10.02x | -- | HK$1.46B |
02443HKAUTOSTREETS | -47.50x | -- | HK$749.40M |
02138HKEC HEALTHCARE | -1.63x | 107.09% | HK$657.79M |
06966HKC WAN TONG YUAN | -485.22x | -- | HK$600.00M |
03650HKKEEP | -10.08x | 73.82% | HK$563.26M |
02700HKGREEN INTL HLDG | -326.85x | -- | HK$382.74M |
01939HKSHANGSHAN GOLD | -14.82x | -- | HK$322.48M |
08483HKMAX SIGHT GROUP | -35.15x | -- | HK$236.00M |
00922HKANXIANYUAN CH | -1.84x | -- | HK$213.25M |
01683HKHOPE LIFE INT | -68.10x | -- | HK$212.75M |
01739HKQEEKA HOME | -1.44x | -- | HK$140.84M |
08360HKBASIC H NEWLIFE | -3.31x | -- | HK$84.00M |
00919HKMODERNHEALTHTEC | -38.50x | -- | HK$67.84M |
08181HKKS SMART MGMT | -1.13x | -- | HK$54.19M |
00079HKCENTURY LEGEND | -1.10x | -- | HK$36.85M |
08455HKLAI GROUP | -2.64x | -- | HK$24.96M |
08173HKHEPHAESTUS HLDG | -3.14x | -- | HK$23.69M |
08296HKSINO-LIFE GROUP | -1.25x | -- | HK$18.43M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
